Isoliquiritigenin Derivative Regulates miR-374a/BAX Axis to Suppress Triple-Negative Breast Cancer Tumorigenesis and Development

Triple-negative breast cancer (TNBC) is a subtype of breast cancer that accounts for the largest proportion of breast cancer-related deaths. Thus, it is imperative to search for novel drug candidates with potent anti-TNBC effects. Recent studies suggest that isoliquiritigenin (ISL) can significantly...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Fu, Xiong, Liang, Xie, Xiaofang, Tang, Hailin, Huang, Ruizhen, Peng, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137655/
https://www.ncbi.nlm.nih.gov/pubmed/32296334
http://dx.doi.org/10.3389/fphar.2020.00378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137655/
https://www.ncbi.nlm.nih.gov/pubmed/32296334
http://dx.doi.org/10.3389/fphar.2020.00378

Ejemplares similares